8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 17, 2021 (February 11, 2021)

 

 

Crescent Capital BDC, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   814-01132   47-3162282

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

11100 Santa Monica Blvd., Suite 2000,

Los Angeles, CA

  90025
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (310) 235-5900

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to 12(b) of the Act:

 

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   CCAP   The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.001 per share

(Title of class)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 1.01.

Entry into a Material Definitive Agreement.

On February 17, 2021, Crescent Capital BDC, Inc., a Maryland corporation (the “Company”), entered into a First Supplement and Amendment to Note Purchase Agreement (the “First Supplement”) by and among the Company, the qualified institutional investors named therein (the “Series 2021A Additional Purchasers”), and, solely with respect to the amendments reflected in Sections 5 and 7 of the First Supplement, Sun Life Assurance Company of Canada and Sun Life Financial Trust, Inc. (collectively, the “Initial Purchasers”) governing the issuance of up to $135.0 million in aggregate principal amount of senior unsecured notes (the “Series 2021A Notes”). The First Supplement supplements the Note Purchase Agreement, dated July 30, 2020 by and among the Company and the Initial Purchasers (the “Master Note Purchase Agreement” and together with the First Supplement, the “Note Purchase Agreement”) pursuant to which the Company previously issued $50.0 million in aggregate principal amount of its 5.95% senior unsecured notes due July 30, 2020. The Series 2021A Notes have a fixed interest rate of 4.00% and will be due on February 17, 2026 unless redeemed, purchased or prepaid prior to such date by the Company or its affiliates in accordance with their terms. Interest on the Series 2021A Notes will be due semiannually. This interest rate is subject to increase (up to 6.95%) during any time that, subject to certain exceptions, the Series 2021A Notes do not have an investment grade rating of BBB- or better. The Series 2021A Notes will be issued in two closings on or before May 17, 2021. The initial issuance of $50.0 million aggregate principal amount of Series 2021A Notes closed on February 17, 2021. The issuance of the remaining $85.0 million aggregate principal amount of notes is expected to occur on or before May 17, 2021, subject to customary closing conditions. In addition, the Company will be obligated to offer to repay the Series 2021A Notes at par if certain change in control events occur. The Series 2021A Notes are general unsecured obligations of the Company that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by the Company.

The Company intends to use the net proceeds to repay certain indebtedness, which may include repaying its remaining InterNotes® or repaying indebtedness outstanding under its debt facilities, and for other general corporate purposes. The Company may re-borrow under its debt facilities for general corporate purposes, which include investing in portfolio companies in accordance with its investment objective.

The Note Purchase Agreement contains customary terms and conditions for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants such as information reporting, maintenance of the Company’s status as a business development company within the meaning of the Investment Company Act of 1940, as amended, and a regulated investment company under the Internal Revenue Code of 1986, as amended, minimum shareholders’ equity, minimum asset coverage ratio, minimum interest coverage ratio and prohibitions on certain fundamental changes of the Company. The Note Purchase Agreement also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under other indebtedness of the Company or certain significant subsidiaries, certain judgements and orders, and certain events of bankruptcy.

The Series 2021A Notes were offered in reliance on Section 4(a)(2) of Securities Act of 1933, as amended (the “Securities Act”). The Series 2021A Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

The information on this Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to purchase the Series 2021A Notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

The description above is only a summary of the material provisions of the Note Purchase Agreement and is qualified in its entirety by reference to the copy of the First Supplement which is filed as Exhibit 10.1 to this current report on Form 8-K and is incorporated herein by reference thereto.

 

Item 2.03.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth above under Item 1.01 is incorporated by reference herein.

 

Item 7.01.

Regulation FD Disclosure.

On February 17, 2021, the Company issued a press release, included herewith as Exhibit 99.1 and by this reference incorporated herein.

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such filing.

 

2


Item 8.01.

Other Events.

On February 11, 2021, the Company notified U.S. Bank National Association, the trustee (the “Trustee”) for the Company’s direct unsecured fixed interest rate obligations (collectively, the “InterNotes®”) that it intended to redeem all of its outstanding InterNotes®. Each series of InterNotes® was issued by a separate trust administered by the Trustee and the InterNotes® bear interest at fixed interest rates ranging between 6.25% and 6.75% and offer a variety of maturities ranging between 2021 and 2022. On February 15, 2021, Tranches 10, 11 and 12 of the InterNotes® matured and were repaid by the Company at par. At the time of such repayment, the outstanding principal amount on Tranche 10 was $2,165,000, Tranche 11 was $2,688,000, and Tranche 12 was $548,000.

The Company has informed the Trustee that it expects to redeem all of the remaining outstanding InterNotes® on or shortly after March 19, 2021 (the “Redemption”). The aggregate principal amount of InterNotes® to be redeemed in the Redemption is $11,017,000, consisting of : (i) Tranche 1: $1,331,000, (ii) Tranche 7: $87,000, (iii) Tranche 13: $1,744,000, (iv) Tranche 14: $872,000, (v) Tranche 15: $711,000, (vi) Tranche 16: $2,816,000, (vii) Tranche 17: $787,000, and (viii) Tranche 18: $2,669,000. The price to be paid by the Company in connection with the Redemption is equal to 100% of the principal amount of the InterNotes® to be redeemed plus accrued and unpaid interest thereon to, but excluding, the date of redemption. Following the Redemption, none of the InterNotes® will remain outstanding.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit
Number
  

Description

10.1    First Supplement and Amendment to Note Purchase Agreement, dated February 17, 2021, by and among Crescent Capital BDC, Inc. and the Purchasers signatory thereto.†
99.1    Press Release, dated February 17, 2021, of Crescent Capital BDC, Inc.

 

Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a copy of such schedules or exhibits, or any section thereof, to the SEC upon request.

 

3


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CRESCENT CAPITAL BDC, INC.
Date: February 17, 2021   By:    

/s/ Gerhard Lombard

  Name:     Gerhard Lombard
  Title:     Chief Financial Officer

 

4

EX-10.1

Exhibit 10.1

EXECUTION COPY

 

 

 

CRESCENT CAPITAL BDC, INC.

FIRST SUPPLEMENT AND AMENDMENT TO NOTE PURCHASE AGREEMENT

Dated as of February 17, 2021

 

  Re:

$135,000,000 4.00% Series 2021A Senior Notes

Due FEBRUARY 17, 2026

 

 

 


CRESCENT CAPITAL BDC, INC.

11100 Santa Monica Blvd., Suite 2000,

Los Angeles, CA 90025

Dated as of

February 17, 2021

To the Series 2021A Additional

Purchaser(s) named in

Schedule A hereto

Ladies and Gentlemen:

This First Supplement and Amendment to Note Purchase Agreement (the “Supplement”) is among CRESCENT CAPITAL BDC, INC., a Maryland corporation (the “Company”), the institutional investors named on Schedule A attached hereto (the “Series 2021A Additional Purchasers”), and solely with respect to the amendments reflected in sections 5 and 7 hereof, the holders of the Series 2020A Notes (as hereinafter defined).

Reference is hereby made to that certain Master Note Purchase Agreement dated July 30, 2020 (the “Note Purchase Agreement”) among the Company and the Purchasers listed on the Purchaser Schedule thereto pursuant to which the Company issued $50,000,000 aggregate principal amount of its 5.95% Series 2020A Senior Notes due July 30, 2023 (the “Series 2020A Notes”). All capitalized terms not otherwise defined herein shall have the same meanings as specified in the Note Purchase Agreement. Reference is further made to Section 4.17 of the Note Purchase Agreement which requires that, prior to the delivery of any Additional Notes, the Company and each Additional Purchaser shall execute and deliver a Supplement.

The Company hereby agrees with the Series 2021A Additional Purchaser(s) as follows:

1. The Company has authorized the issue and sale of $135,000,000 aggregate principal amount of its 4.00% Series 2021A Senior Notes due February 17, 2026 (the “Series 2021A Notes”). The Series 2021A Notes, together with the Series 2020A Notes issued pursuant to the Note Purchase Agreement and each series of Additional Notes which may from time to time hereafter be issued pursuant to the provisions of Section 2.2 of the Note Purchase Agreement, are collectively referred to as the “Notes” (such term shall also include any such notes issued in substitution therefor pursuant to Section 13 of the Note Purchase Agreement). The Series 2021A Notes shall be substantially in the form set out in Exhibit 1 hereto with such changes therefrom, if any, as may be approved by the Series 2021A Additional Purchaser(s) and the Company.


2. Subject to the terms and conditions hereof and as set forth in the Note Purchase Agreement and on the basis of the representations and warranties hereinafter set forth, the Company agrees to issue and sell to each Series 2021A Additional Purchaser, and each Series 2021A Additional Purchaser agrees to purchase from the Company, Series 2021A Notes in the principal amount set forth opposite such Series 2021A Additional Purchaser’s name on Schedule A hereto at a price of 100% of the principal amount thereof on such Series 2021A Closing Date (as defined below).

3. The sale and purchase of the Series 2021A Notes to be purchased by each Series 2021A Additional Purchaser shall occur at the offices of Chapman and Cutler LLP, 111 West Monroe Street, Chicago, Illinois 60603, at 9:00 A.M. Chicago time, at not more than two closings (each individually a “Series 2021A Closing” and, collectively, the “Series 2021A Closings”).

(a) The first Series 2021A Closing shall be held on February 17, 2021 (the “First Series 2021A Closing Date”); provided, however, that the First Series 2021A Closing Date may be moved to such other Business Day thereafter on or prior to February 19, 2021 as may be agreed upon by the Company and the Additional Purchasers purchasing such Series 2021A Notes at such Series 2021A Closing.

(b) The second Series 2021A Closing shall be held on such Business Day as the Company shall designate (the “Second Series 2021A Closing Date”) by notice to each Additional Purchaser purchasing Series 2021A Notes at such Series 2021A Closing at least ten days prior to the Second Series 2021A Closing Date; provided, however, that the Second Series 2021A Closing Date may not be later than May 17, 2021 unless agreed upon by the Company and the Additional Purchasers purchasing such Series 2021A Notes at such Series 2021A Closing (each of the First Series 2021A Closing Date and the Second Series 2021A Closing Date being a “Series 2021A Closing Date”).

At each Series 2021A Closing, subject to section 4 hereof and Section 4 of the Note Purchase Agreement, the Company will deliver to each Series 2021A Additional Purchaser the Series 2021A Notes to be purchased by such Series 2021A Additional Purchaser at such Series 2021A Closing in the form of a single Series 2021A Note (or such greater number of Series 2021A Notes in denominations of at least $100,000 as such Series 2021A Additional Purchaser may request) dated the date of such Series 2021A Closing and registered in such Series 2021A Additional Purchaser’s name (or in the name of such Series 2021A Additional Purchaser’s nominee), against delivery by such Series 2021A Additional Purchaser to the Company or its order of immediately available funds in the amount of the purchase price therefor by wire transfer of immediately available funds for the account of the Company pursuant to the applicable funding instructions in Section 4.10 of the Note Purchase Agreement. If, at a Series 2021A Closing, the Company shall fail to tender such Series 2021A Notes to any Series 2021A Additional Purchaser as provided above in this Section 3, or any of the conditions specified in Section 4 shall not have been fulfilled to any Series 2021A Additional Purchaser’s satisfaction, such Series 2021A Additional Purchaser shall, at such Series 2021A Additional Purchaser’s election, be relieved of all further obligations under this Agreement, without thereby waiving any rights such Series 2021A Additional Purchaser may have by reason of such failure or such nonfulfillment.

 

2


4. The obligation of each Series 2021A Additional Purchaser to purchase and pay for the Series 2021A Notes to be sold to such Series 2021A Additional Purchaser at a Series 2021A Closing is subject to the fulfillment to such Series 2021A Additional Purchaser’s satisfaction, prior to the Series 2021A Closing, of the conditions set forth in Section 4 of the Note Purchase Agreement with respect to the Series 2021A Notes to be purchased at such Series 2021A Closing as if each reference to “2020A Notes” or “Notes,” “Closing” and “Purchaser” set forth therein was modified to refer to “Series 2021A Notes,” “Series 2021A Closing” and “Series 2021A Additional Purchaser” (each as defined in this Supplement) and to the following additional conditions:

(a) Except as supplemented, amended or superseded by the representations and warranties set forth in Exhibit A hereto, each of the representations and warranties of the Company set forth in Section 5 of the Note Purchase Agreement shall be correct as of the applicable Series 2021A Closing Date (except for representations and warranties which apply to a specific earlier date which shall be true as of such earlier date or as of the date specified in Exhibit A to the extent such provision is superseded in Exhibit A) and the Company shall have delivered to each Series 2021A Additional Purchaser an Officer’s Certificate, dated the date of the applicable Series 2021A Closing Date certifying that such condition has been fulfilled.

(b) Contemporaneously with each Series 2021A Closing, the Company shall sell to each Series 2021A Additional Purchaser, and each Series 2021A Additional Purchaser shall purchase, the Series 2021A Notes to be purchased by such Series 2021A Additional Purchaser on such Series 2021A Closing Date as specified in Schedule A.

(c) In the case of the Second Series 2021A Closing, the transactions contemplated herein with respect to the First Series 2021A Closing shall have been consummated in accordance with the terms and provisions hereof, except to the extent of any failure of such transactions so to have been consummated that was caused by any failure of any Series 2021A Additional Purchaser to perform its obligations hereunder.

5. The terms of Section 8 of the Note Purchase Agreement shall apply to the Series 2021A Notes except that, Sections 8.2, 8.3 and 8.5 of the Note Purchase Agreement shall be amended and restated in their entirety to read as follows:

Section 8.2. Optional Prepayments (a) The Company may, at its option, upon notice as provided below, prepay at any time all, or from time to time any part of, any Series of the Notes, in an amount not less than $1,000,000, in the case of a partial prepayment, at 100% of the principal amount so prepaid, together with interest accrued thereon to the date of such prepayment, plus the Make-Whole Amount determined for the prepayment date with respect to such principal amount; provided, that, so long as no Default or Event of Default shall then exist, at any time on or after the date that is six months prior to the Maturity Date of such Series of Notes the Company may, at its option, upon notice as provided below, prepay all or any part of such Series of Notes at 100% of the principal amount so prepaid, together with, in each case, accrued interest to the prepayment date. The Company will give each holder of the applicable Series of Notes written notice of each optional

 

3


prepayment under this Section 8.2(a) not less than 10 days and not more than 60 days prior to the date fixed for such prepayment unless the Company and the holders of more than 50% in principal amount of the applicable Series of Notes at the time outstanding (exclusive of Notes then owned by the Company or any of its Affiliates) agree to another time period pursuant to Section 17. Each such notice shall specify such date (which shall be a Business Day), the aggregate principal amount of such Series of Notes to be prepaid on such date, the principal amount of each such Series of Notes held by such holder to be prepaid (determined in accordance with Section 8.3), and the interest to be paid on the prepayment date with respect to such principal amount being prepaid, and shall be accompanied by a certificate of a Senior Financial Officer as to the estimated Make-Whole Amount due in connection with such prepayment (calculated as if the date of such notice were the date of the prepayment), setting forth the details of such computation. Two Business Days prior to such prepayment, the Company shall deliver to each holder of the applicable Series Notes a certificate of a Senior Financial Officer specifying the calculation of such Make-Whole Amount as of the specified prepayment date.

(b) Notwithstanding anything contained in this Section 8.2 to the contrary, if and so long as any Default or Event of Default shall have occurred and be continuing, any prepayment of the Notes pursuant to the provisions of Section 8.2(a) shall be allocated among all of the Notes of all Series at the time outstanding in proportion, as nearly as practicable, to the respective unpaid principal amounts thereof.

Section 8.3. Allocation of Partial Prepayments. In the case of each partial prepayment of a Series of the Notes pursuant to Section 8.2(a), the principal amount of the Notes to be prepaid shall be allocated among all of the Notes of such Series at the time outstanding in proportion, as nearly as practicable, to the respective unpaid principal amounts thereof not theretofore called for prepayment.

Section 8.5. Purchase of Notes The Company will not and will not permit any Controlled Entity to purchase, redeem, prepay or otherwise acquire, directly or indirectly, any of the outstanding Notes of any Series except (a) upon the payment or prepayment of the Notes of such Series in accordance with this Agreement and the Notes or (b) pursuant to an offer to purchase made by the Company or a Controlled Entity pro rata to the holders of all Notes of such Series at the time outstanding upon the same terms and conditions, provided, that if and so long as any Default or

 

4


Event of Default shall have occurred and be continuing, such written offer shall be made pro rata to the holders of all Notes of all Series outstanding upon the same terms and conditions. Any such offer shall provide each holder with sufficient information to enable it to make an informed decision with respect to such offer, and shall remain open for at least 10 Business Days. If the holders of more than 20% of the principal amount of the Notes of the applicable Series then outstanding accept such offer, the Company shall promptly notify the remaining holders of such Series of Notes of such fact and the expiration date for the acceptance by holders of such Series of Notes of such offer shall be extended by the number of days necessary to give each such remaining holder at least five Business Days from its receipt of such notice to accept such offer. The Company will promptly cancel all Notes of a particular Series acquired by it or any Controlled Entity pursuant to any payment, prepayment or purchase of such Series of Notes pursuant to this Agreement and no Notes may be issued in substitution or exchange for any such Series of Notes.

6. Each Series 2021A Additional Purchaser represents and warrants that the representations and warranties set forth in Section 6 of the Note Purchase Agreement are true and correct on the date hereof with respect to the purchase of the Series 2021A Notes by such Series 2021A Additional Purchaser as if each reference to “2020A Notes” or “Notes,” “Series 2020A Closing” and “Purchaser” set forth therein was modified to refer to “Series 2021A Notes,” “Series 2021A Closing” and “Series 2021A Additional Purchaser” and each reference to “this Agreement” therein was modified to refer to the Note Purchase Agreement as supplemented by this Supplement.

7. The terms of Section 7.5 of the Note Purchase Agreement shall apply to the Series 2021A Notes except that Schedule 7.5 shall be amended and restated in its entirety in the form of Schedule 7.5 to this Supplement.

8. The terms of Section 10 of the Note Purchase Agreement shall apply to the Series 2021A Notes except that Schedule 10.1 shall be amended and restated in its entirety in the form of Schedule 10.1 to this Supplement.

9. The Company and each Series 2021A Additional Purchaser agree to be bound by and comply with the terms and provisions of the Note Purchase Agreement as fully and completely as if such Series 2021A Additional Purchaser were an original signatory to the Note Purchase Agreement.

10. Each Series 2021A Additional Purchaser acknowledges and agrees that Chapman and Cutler LLP shall, as such Series 2021A Additional Purchaser’s true and lawful attorney-in-fact, accept on its behalf delivery of the Series 2021A Notes to be purchased by such Series 2021A Additional Purchaser at the applicable Series 2021A Closing set forth in Section 3 hereof. Any person dealing with the Company may conclusively presume and rely upon the fact that any instrument acknowledging such delivery executed by such attorney-in-fact is authorized, regular and binding, without further inquiry.

 

5


11. This Supplement shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the law of the State of New York, excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State.

12. This Supplement may be executed in any number of counterparts, each of which shall be an original but all of which together shall constitute one instrument. Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all, of the parties hereto. The parties agree to electronic contracting and signatures with respect to this Supplement. Delivery of an electronic signature to, or a signed copy of, this Supplement by facsimile, email or other electronic transmission shall be fully binding on the parties to the same extent as the delivery of the signed originals and shall be admissible into evidence for all purposes.

 

6


The execution hereof shall constitute a contract between the Company and the Series 2021A Additional Purchaser(s) for the uses and purposes hereinabove set forth, and this agreement may be executed in any number of counterparts, each executed counterpart constituting an original but all together only one agreement.

 

CRESCENT CAPITAL BDC, INC.
By:   /s/ Gerhard Lombard
  Name:   Gerhard Lombard
  Title:   Chief Financial Officer

 

7


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

AMERICAN REPUBLIC INSURANCE COMPANY
BETTERLIFE
BLUE CROSS AND BLUE SHIELD OF
FLORIDA, INC.
CATHOLIC LIFE INSURANCE
CATHOLIC UNITED FINANCIAL
FARM BUREAU GENERAL INSURANCE COMPANY OF MICHIGAN
FARM BUREAU MUTUAL INSURANCE COMPANY OF MICHIGAN
FIDELITY LIFE ASSOCIATION, A LEGAL RESERVE LIFE INSURANCE COMPANY
GBU FINANCIAL LIFE
GLEANER LIFE INSURANCE SOCIETY
LIFECARE ASSURANCE COMPANY
MINNESOTA LIFE INSURANCE COMPANY
SECURIAN LIFE INSURANCE COMPANY
THE CINCINNATI INSURANCE COMPANY
By: Securian Asset Management, Inc.
By:  

/s/ Robin J. Lenarz

  Name:   Robin J. Lenarz
  Title:   Vice President


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

EQUITRUST LIFE INSURANCE COMPANY
By:   /s/ Kenyatta K. Matheny
  Name:   Kenyatta K. Matheny
  Title:   Chief Investment Officer

 

2


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

EQUITABLE FINANCIAL LIFE INSURANCE COMPANY
By:   /s/ Amy Judd
  Name:   Amy Judd
  Title:   Investment Officer

 

3


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

SUN LIFE ASSURANCE COMPANY OF CANADA, acting through its Bermuda Branch
By:   /s/ Alec Svoboda
  Name:   Alec Svoboda
  Title:   Managing Director
    Private Fixed Income
By:   /s/ Russell Goldenberg
  Name:   Russell Goldenberg
  Title:   Senior Director
    Private Fixed Income
SUN LIFE ASSURANCE COMPANY OF CANADA, acting through its U.S. Branch
By:   /s/ David Belanger
  Name:   David Belanger
  Title:   Managing Director
By:   /s/ Arthur Baril
  Name:   Arthur Baril
  Title:   Senor Director

 

4


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

AMERICAN HEALTH AND LIFE INSURANCE COMPANY
By:   Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

5


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

THE BALTIMORE LIFE INSURANCE COMPANY
By:   Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

6


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

ELECTRIC INSURANCE COMPANY
By:   Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

7


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

ILLINOIS MUTUAL LIFE INSURANCE COMPANY
By:   Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

8


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

KENTUCKY EMPLOYERS’ MUTUAL INSURANCE AUTHORITY
By:   Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

9


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

MT. HAWLEY INSURANCE COMPANY
By:   Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

10


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

NATIONAL BENEFIT LIFE INSURANCE COMPANY
By: Conning, Inc., as Investment Manager
By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

11


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

NODAK INSURANCE COMPANY

By: Conning, Inc., as Investment Manager

By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

12


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

PEKIN LIFE INSURANCE COMPANY

By: Conning, Inc., as Investment Manager

By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

13


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

PENN NATIONAL SECURITY INSURANCE COMPANY

By: Conning, Inc., as Investment Manager

By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

14


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

PINNACOL ASSURANCE

By: Conning, Inc., as Investment Manager

By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

15


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

PRIMERICA LIFE INSURANCE COMPANY

By: Conning, Inc., as Investment Manager

By:   /s/ John Petchler
  Name: John Petchler
  Title: Director

 

16


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

STARR INDEMNITY & LIABILITY COMPANY
By: Conning, Inc., as Investment Manager
By:   /s/ John Petchler
 

Name: John Petchler

 

Title: Director

 

17


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

STARR INSURANCE & REINSURANCE LIMITED
By: Conning, Inc., as Investment Manager
By:   /s/ John Petchler
 

Name: John Petchler

 

Title: Director

 

18


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

TRITON INSURANCE COMPANY
By: Conning, Inc., as Investment Manager
By:   /s/ John Petchler
 

Name: John Petchler

 

Title: Director

 

19


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

THE GUARDIAN LIFE INSURANCE COMPANY OF
AMERICA
By  

/s/ Trinh T. Nguyen

 

Name: Trinh T. Nguyen

 

Title: Managing Director

 

20


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

THRIVENT FINANCIAL FOR LUTHERANS
By:   /s/ Robinson Ewald
 

Name: Robinson Ewald

 

Title: Intermediate Analyst

 

21


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

AMERICAN GENERAL LIFE INSURANCE COMPANY

AMERICAN HOME ASSURANCE COMPANY

THE UNITED STATES LIFE INSURANCE COMPANY IN
THE CITY OF NEW YORK

By: AIG Asset Management (U.S.), LLC, as

Investment Adviser

By:  

/s/ Philip Kroger

 

Name: Philip Kroger

 

Title: Vice President

 

22


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

GREAT AMERICAN LIFE INSURANCE COMPANY
By:   /s/ Mark F. Muething
  Name: Mark F. Muething
  Title: President
GREAT AMERICAN INSURANCE COMPANY
By:   /s/ Stephen C. Beraha
  Name: Stephen C. Beraha
  Title: Assistant Vice President

 

23


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

SELECTIVE WAY INSURANCE COMPANY
By:   /s/ Joseph O. Eppers
  Name: Joseph O. Eppers
  Title: SVP, Chief Investment Officer

 

24


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

OHIO NATIONAL LIFE ASSURANCE

    CORPORATION

By:   /s/ Brenda Kalb
  Name:  Brenda Kalb
  Title:    Vice President

 

25


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

ANTHEM LIFE INSURANCE COMPANY
ANTHEM BLUE CROSS LIFE AND HEALTH INSURANCE COMPANY
LOUISIANA HEALTH SERVICE & INDEMNITY COMPANY
TEXAS MUTUAL INSURANCE COMPANY
EMPIRE HEALTHCHOICE ASSURANCE INC.
SECURITY HEALTH PLAN OF WISCONSIN, INC.
BLUE CROSS OF CALIFORNIA
THE TOA REINSURANCE COMPANY OF AMERICA
By:   Western Asset Management Company, as investment manager
By:   /s/ Adam Wright
  Name: Adam Wright
  Title: Manager, U.S. Legal Affairs

 

26


This Agreement is hereby

accepted and agreed to as

of the date hereof.

 

FARM BUREAU LIFE INSURANCE COMPANY
By:   /s/ Herman L. Riva
  Name: Herman L. Riva
  Title:   Securities Vice President

 

27


Accepted as of as of the date of the Supplement solely with respect to the amendments reflected in sections 5 and 7 hereof

 

SUN LIFE ASSURANCE COMPANY OF CANADA, as a holder of Series 2020A Notes

By

  /s/ Alec Svoboda

Name:

  Alec Svoboda

Title:

  Managing Director, Private Fixed Income

By

  /s/ Russell Goldenberg

Name:

  Russell Goldenberg

Title:

  Senior Director, Private Fixed Income

SUN LIFE FINANCIAL TRUST INC., as a holder of Series 2020A Notes

By

  /s/ jeffery mayer

Name:

  jeffery mayer

Title:

  Managing Director, Private Securitization Finance

By

  /s/ Rajan Ariyur

Name:

  Rajan Ariyur

Title:

  Managing Director

 

28


SCHEDULE A

INFORMATION RELATING TO SERIES 2021A ADDITIONAL PURCHASERS

[Attached]

 

SCHEDULE A

(to Supplement)


SUPPLEMENTAL REPRESENTATIONS

The Company represents and warrants to each Additional Purchaser that except as hereinafter set forth in this Exhibit A, each of the representations and warranties set forth in Section 5 of the Note Purchase Agreement (other than representations and warranties that apply solely to a specific earlier date which shall be true as of such earlier date and other than the Section references hereinafter set forth) is true and correct in all material respects as of the date hereof with respect to the Series 2021A Notes with the same force and effect as if each reference to “the Notes” set forth herein or therein was modified to refer to the “Series 2021A Notes” and each reference to “this Agreement” therein was modified to refer to the Note Purchase Agreement as supplemented by the Supplement. The Section references hereinafter set forth correspond to the similar sections of the Note Purchase Agreement which are supplemented hereby:

Section 5.3. Disclosure. This Agreement, the financial statements listed in Schedule 5.5 and the documents, certificates or other writings delivered to the Series 2021A Additional Purchasers by or on behalf of the Company prior to February 5, 2021 in connection with the transactions contemplated hereby and identified in Schedule 5.3 (this Agreement and such documents, certificates or other writings and such financial statements delivered to each Series 2021A Additional Purchaser being referred to, collectively, as the “Disclosure Documents”), taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. Except as disclosed in the Disclosure Documents, since September 30, 2019, there has been no change in the financial condition, operations, business or properties of the Company or any Subsidiary except changes that could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no fact known to the Company that would reasonably be expected to have a Material Adverse Effect that has not been set forth herein or in the Disclosure Documents.

Section 5.4. Organization and Ownership of Shares of Subsidiaries; Affiliates. (a) Schedule 5.4 contains (except as noted therein) complete and correct lists as of the date of the First Series 2021A Closing of (i) the Company’s Subsidiaries, showing, as to each Subsidiary, the name thereof, the jurisdiction of its organization, the percentage of shares of each class of its capital stock or similar equity interests outstanding owned by the Company and each other Subsidiary and whether such Subsidiary is a Subsidiary Guarantor, and (ii) the Company’s directors and senior officers.

Section 5.5. Financial Statements; Material Liabilities. The Company has delivered to each Series 2021A Additional Purchaser copies of the financial statements of the Company and its Subsidiaries listed on Schedule 5.5. All of such financial statements (including in each case the related schedules and notes, but excluding all financial projections, pro forma financial information and other forward-looking information) fairly present in all material respects the consolidated financial position of the Company and its Subsidiaries as of the respective dates specified in such Schedule and the consolidated results of their operations and cash flows for the respective periods so specified and have been prepared in accordance with GAAP consistently applied throughout the periods involved except as set forth in the notes thereto (subject, in the case of any interim financial statements, to normal year-end adjustments and lack of footnotes).


Section 5.13. Private Offering by the Company. Neither the Company nor anyone acting on its behalf has offered the Series 2021A Notes or any substantially similar debt Securities for sale to, or solicited any offer to buy the Series 2021A Notes or any substantially similar debt Securities from, or otherwise approached or negotiated in respect thereof with, any Person other than not more than 30 Institutional Investors, including the Series 2021A Additional Purchasers, each of which has been offered the Series 2021A Notes at a private sale for investment. Neither the Company nor anyone acting on its behalf has taken, or will take, any action that would subject the issuance or sale of the Series 2021A Notes to the registration requirements of section 5 of the Securities Act or to the registration requirements of any Securities or blue sky laws of any applicable jurisdiction.

Section 5.14. Use of Proceeds; Margin Regulations. The Company will apply the proceeds of the sale of the Series 2021A Notes hereunder for the repayment of indebtedness and other general corporate purposes of the Company and its Subsidiaries and as otherwise set forth in the Disclosure Documents. No part of the proceeds from the sale of the Series 2021A Notes hereunder will be used, directly or indirectly, for the purpose of buying or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221), or for the purpose of buying or carrying or trading in any Securities under such circumstances as to involve the Company in a violation of Regulation X of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220). Margin stock does not constitute more than 5% of the value of the consolidated assets of the Company and its subsidiaries and the Company does not have any present intention that margin stock will constitute more than 5% of the value of such assets. As used in this Section, the terms “margin stock” and “purpose of buying or carrying” shall have the meanings assigned to them in said Regulation U.

Section 5.15. Existing Indebtedness; Future Liens. (a) Except as described therein, Schedule 5.15 sets forth a complete and correct list of all outstanding Indebtedness of the Company and its Subsidiaries as of December 31, 2020, since which date there has been no Material change in the amounts, interest rates, sinking funds, installment payments or maturities of the Indebtedness of the Company or its Subsidiaries. As of December 31, 2020, neither the Company nor any Subsidiary is in default and no waiver of default is currently in effect, in the payment of any principal or interest on any Indebtedness of the Company or such Subsidiary and, to the knowledge of the Company, no event or condition exists with respect to any Indebtedness of the Company or any Subsidiary that would permit (or that with notice or the lapse of time, or both, would permit) one or more Persons to cause such Indebtedness to become due and payable before its stated maturity or before its regularly scheduled dates of payment.

 

- 2 -


SCHEDULE 5.3

DISCLOSURE

MATERIALS

[Attached]

 

SCHEDULE 5.3

(to Supplement)


SCHEDULE 5.4

SUBSIDIARIES OF THE COMPANY AND

OWNERSHIP OF SUBSIDIARY STOCK

[Attached]

 

SCHEDULE 5.4

(to Supplement)


SCHEDULE 5.5

FINANCIAL STATEMENTS

[Attached]

 

SCHEDULE 5.5

(to Supplement)


SCHEDULE 5.15

EXISTING INDEBTEDNESS OF THE COMPANY AND ITS SUBSIDIARIES

[Attached]


SCHEDULE 7.5

NON COMPETITORS

[Attached]

 

SCHEDULE 7.5

(to Supplement)


SCHEDULE 10.1

TRANSACTIONS WITH AFFILIATES

[Attached]

 

SCHEDULE 10.1


EXHIBIT 1

[FORM OF SERIES 2021A NOTE]

CRESCENT CAPITAL BDC, INC.

4.00% SERIES 2021A SENIOR NOTE DUE FEBRUARY 17, 2026

 

No. [_____]    [Date]
$[_______]    PPN 225655 A@8

FOR VALUE RECEIVED, the undersigned, CRESCENT CAPITAL BDC, INC. (herein called the “Company”), a corporation organized and existing under the laws of the State of Maryland, hereby promises to pay to [____________], or registered assigns, the principal sum of [_____________________] DOLLARS (or so much thereof as shall not have been prepaid) on February 17, 2026 (the “Maturity Date”), with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 4.00% per annum, as may be adjusted in accordance with Section 1.3 of the Note Purchase Agreement (as hereinafter defined), from the date hereof, payable semiannually, on the 17th day of February and August in each year, commencing with the February or August next succeeding the date hereof, and on the Maturity Date, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, (x) on any overdue payment of interest and (y) during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the Default Rate (as defined in the hereinafter defined Master Note Purchase Agreement), payable semiannually as aforesaid (or, at the option of the registered holder hereof, on demand).

Payments of principal of, interest on and any Make-Whole Amount with respect to this Note are to be made in lawful money of the United States of America at the principal office of the Investment Adviser in New York, New York located on the date hereof at 10 Hudson Yards, 41st Floor, New York, NY 10001 or at such other place as the Company shall have designated by written notice to the holder of this Note as provided in the Master Note Purchase Agreement referred to below.

This Note is one of a series of Senior Notes (the “Notes”) issued pursuant to a Supplement to the Master Note Purchase Agreement, dated July 30, 2020 (as from time to time amended, the “Master Note Purchase Agreement”), among the Company, the Purchasers named therein and Additional Purchasers of Notes from time to time issued pursuant to any Supplement to the Note Purchase Agreement. This Note and the holder hereof are entitled equally and ratably with the holders of all other Notes of all series from time to time outstanding under the Note Purchase Agreement to all the benefits provided for thereby or referred to therein. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 20 of the Master Note Purchase Agreement and (ii) made the representation set forth in Section 6.2 of the Master Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Master Note Purchase Agreement.

 

EXHIBIT 1

(to Supplement)


This Note is a registered Note and, as provided in the Master Note Purchase Agreement, upon surrender of this Note for registration of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the name of, the transferee. Prior to due presentment for registration of transfer, the Company may treat the Person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the Company will not be affected by any notice to the contrary.

This Note and the holder hereof are entitled equally and ratably with the holders of all of the Notes to the rights and benefits provided pursuant to the terms and provisions of each Subsidiary Guarantee (as such term is defined in the Note Purchase Agreement), if any. Reference is hereby made to the foregoing for a statement of the nature and extent of the benefits for the Notes afforded thereby and the rights of the holders of the Notes.

This Note is subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise.

If an Event of Default occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement.

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall be governed by, the law of the State of New York, excluding choice-of-law principles of the law of such State that would permit application of the laws of a jurisdiction other than such State.

 

CRESCENT CAPITAL BDC, INC.
By:    
  [Title]

 

- 2 -

EX-99.1

Exhibit 99.1

 

LOGO

Crescent Capital BDC, Inc. Announces Private Placement of $135 Million 4.00% Senior Unsecured Notes Due 2026

LOS ANGELES—February 17, 2021—Crescent Capital BDC, Inc. (the “Company,” “Crescent BDC,” or “our”) (NASDAQ: CCAP) announced today that it has agreed to issue $135 million in aggregate principal amount of 4.00% senior unsecured notes due 2026 (the “Notes”) by entering into a first supplement (the “First Supplement”) to its Note Purchase Agreement dated July 30, 2020 (the “Note Purchase Agreement”). The Notes will be issued in two closings. The initial issuance of $50 million of Notes closed today, February 17, 2021, and the issuance of the remaining $85 million of Notes is expected to occur on or before May 17, 2021, subject to customary closing conditions. The Company also announced that on February 15, 2021, it repaid $5.4 million of its outstanding InterNotes® at par, and has informed the trustee for the InterNotes® that it expects to redeem all of the remaining outstanding InterNotes® on or shortly after March 19, 2021.

The Notes will mature on February 17, 2026 and may be redeemed in whole or in part, at Crescent BDC’s option, at any time or from time to time at par plus a “make-whole” premium, if applicable. The Company intends to use the proceeds of the offering to repay outstanding debt and for general corporate purposes. Except as set forth in the Supplement, the Notes have the same terms as the unsecured notes that the Company previously issued pursuant to the Note Purchase Agreement and the supplements thereto, respectively.

“We are very pleased to announce this debt offering, which was supported by existing and new debt investors whom we would like to welcome as long-term partners,” said Jason Breaux, Chief Executive Officer of Crescent BDC. “The offering improves Crescent BDC’s financial flexibility and funding profile and allows us to continue to pursue attractive new investment opportunities.”

The Notes have not been and will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This news release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

Wells Fargo acted as exclusive placement agent for the Company in connection with the Notes offering.

About Crescent BDC

Crescent BDC is a business development company that seeks to maximize the total return of its stockholders in the form of current income and capital appreciation by providing capital solutions to middle market companies with sound business fundamentals and strong growth prospects. Crescent BDC utilizes the extensive experience, origination capabilities and disciplined investment process of Crescent Capital Group LP (“Crescent”). Crescent BDC is externally managed by Crescent Cap Advisors, a subsidiary of Crescent. Crescent BDC has elected to be regulated as a business development company under the Investment Company Act of 1940. For more information about Crescent BDC, visit http://crescentbdc.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.


About Crescent Capital Group LP

Crescent is a global credit investment manager with approximately $30 billion of assets under management. For nearly 30 years, the firm has focused on below investment grade credit through strategies that invest in marketable and privately originated debt securities including senior bank loans, high yield bonds, and private senior, unitranche, and junior debt securities. Crescent is headquartered in Los Angeles with offices in New York, Boston, and London and more than 180 employees globally. For more information about Crescent, visit www.crescentcap.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.

Contact:

Daniel McMahon

daniel.mcmahon@crescentcap.com

212-364-0149

Forward-Looking Statements

Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results and conditions may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. Crescent BDC undertakes no duty to update any forward-looking statements made herein.